SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on September 22, 2021, covering events occurring on September 20 and September 21, 2021. The filing reports corporate governance changes, specifically the appointment of a new director and an increase in the size of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased its size from six to seven members, effective September 20, 2021.
- Director Appointment: James J. Barry, Ph.D., was appointed as a director to fill the new vacancy. His term expires at the 2022 annual meeting of stockholders or until a successor is elected.
- Compensation Package: Dr. Barry will receive compensation consistent with market practices and the Company's non-employee director policy. Additionally, he was granted 50,000 restricted stock units (RSUs).
- Vesting Schedule: 50% of the RSUs vested immediately upon acceptance, and the remaining 50% will vest on the first anniversary of his appointment, contingent on continued service.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors. The only disclosed event is the press release announcing the appointment of Dr. Barry, which is attached as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the total number of outstanding shares and the impact of the 50,000 RSUs granted to Dr. Barry on potential dilution.
- Confirm the current composition of the Board of Directors and the specific expertise Dr. Barry brings to the Company.
- Review the Company's non-employee director compensation policy to understand the cash compensation component for Dr. Barry.
- Check subsequent filings for the vesting status of the RSUs on the first anniversary of the appointment.